270
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Biological Markers of Oxidative Stress in Cardiovascular Diseases: After so Many Studies, What do We Know?

, &

References

  • Abdellatief SA, Galal AA, Farouk SM, Abdel-Daim MM. (2017). Ameliorative effect of parsley oil on cisplatin-induced hepato-cardiotoxicity: a biochemical, histopathological, and immunohistochemical study. Biomed Pharmacother, 86, 482–491. doi:10.1016/j.biopha.2016.12.038.
  • Aivatidi C, Vourliotakis G, Georgopoulos S, et al. (2011). Oxidative stress during abdominal aortic aneurysm repair-biomarkers and antioxidant’s protective effect: a review. Eur Rev Med Pharmacol Sci, 15, 245–252.
  • Ajibade TO, Oyagbemi AA, Durotoye LA, et al. (2017). Modulatory effects of melatonin and vitaminC on oxidative stress-mediated haemolytic anaemia and associated cardiovascular dysfunctions in rats. J Complement Integr Med, 14, doi:10.1515/jcim-2015-0082.
  • Bayeva M, Gheorghiade M, Ardehali H. (2013). Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol, 61, 599. doi:10.1016/j.jacc.2012.08.1021.
  • Benzer F, Kandemir FM, Ozkaraca M, et al. (2018). Curcumin ameliorates doxorubicin-induced cardiotoxicity by abrogation of inflammation, apoptosis, oxidative DNA damage, and protein oxidation in rats. J Biochem Mol Toxicol, 32, doi:10.1002/jbt.22030.
  • Bjelakovic G, Nikolova D, Gluud LL, et al. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. Jama, 297, 842–857. doi:10.1001/jama.297.8.842.
  • Blankenberg S, Rupprecht HJ, Bickel C, et al. (2003). Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med, 349, 1605–1613. doi:10.1056/NEJMoa030535.
  • Bonafede R, Manucha W. (2018). Nitric oxide and related factors linked to oxidation and inflammation as possible biomarkers of heart failure. Clin Investig Arterioscler, 30, 84–94. doi:10.1016/j.arteri.2017.12.004.
  • Borisenko GG, Kapralov AA, Tyurin VA, et al. (2008). Molecular design of new inhibitors of peroxidase activity of cytochrome c/cardiolipin complezes: fluorescent oxadiazole-derivatized cardiolipin. Biochemistry, 47, 13699–13710. doi:10.1021/bi801507s.
  • Brasen JH, Leppanen O, Inkala M, et al. (2007). Extracellular superoxide dismutase accelerates endothelial recovery and inhibits in-stent restenosis in stented atherosclerotic Watanabe heritable hyperlipidemic rabbit aorta. J Am Coll Cardiol, 50, 2249–2253. doi:10.1016/j.jacc.2007.08.038.
  • Brennan ML, Hazen SL. (2003). Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol, 14, 353–359. doi:10.1097/01.mol.0000083762.66245.51.
  • Bugger H, Abel ED. (2010). Mitochondria in the diabetic heart. Cardiovasc Res, 88, 229–240. doi:10.1093/cvr/cvq239.
  • Cervantes Gracia K, Llanas-Cornejo D, Husi H. (2017). CVD and oxidative stress. J Clin Med, 6, doi:10.3390/jcm6020022.
  • Cherubini A, Ruggiero C, Polidori MC, Mecocci P. (2005). Potential markers of oxidative stress in stroke. Free Radic Biol Med, 39, 841–852. doi:10.1016/j.freeradbiomed.2005.06.025.
  • Chua CC, Hamdy RC, Chua BH. (1998). Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med, 25, 891–897.
  • Constantini D, Bonadonna F. (2010). Patterns of variation of serum oxidative stress markers in two seabird species. Polar Res, 29, 30.-5. doi:10.1111/j.1751-8369.2009.00143.x.
  • Cournot M, Burillo E, Saulnier PJ, et al. (2018). Circulating concentrations of redox biomarkers do not improve the prediction of adverse cardiovascular events in patients with type 2 diabetes mellitus. J Am Heart Assoc, 7, doi:10.1161/JAHA.117.007397.
  • Deidda M, Madonna R, Mango R, et al. (2016). Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection. J Cardiovasc Med (Hagerstown), 17(Suppl 1), S76–83. doi:10.2459/JCM.0000000000000373.
  • Dick SA, Epelman S. (2016). Chronic heart failure and inflammation: what do we really know? Circ Res, 119, 159–176. doi:10.1161/CIRCRESAHA.116.308030.
  • Duncan AJ, Heales SJ. (2005). Nitric oxide and neurological disorders. Mol Aspects Med, 26, 67–96. doi:10.1016/j.mam.2004.09.004.
  • El-Bassossy HM, Ghaleb H, Elberry AA, et al. (2017). Geraniol alleviates diabetic cardiac complications: effect on cardiac ischemia and oxidative stress. Biomed Pharmacother, 88, 1025–1030. doi:10.1016/j.biopha.2017.01.131.
  • Farhangi MA, Nameni G, Hajiluian G, Mesgari-Abbasi M. (2017). Cardiac tissue oxidative stress and inflammation after vitamin D administrations in high fat-diet induced obese rats. BMC Cardiovasc Disord, 17, doi:10.1186/s12872-017-0597-z.
  • Feng X, Luo Z, Ma L, et al. (2011). Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-delta/AMPK pathway. J Cell Mol Med, 15, 1572–1581. doi:10.1111/j.1582-4934.2010.01085.x.
  • Ferreira CS, Vasconcello RS, Pedreira RS, et al. (2014). Alterations to oxidative stress markers in dogs after a short-term stress during transport. J Nutr Sci, 3, e27. doi:10.1017/jns.2014.47.
  • Forstermann U, Munzel T. (2006). Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation, 113, 1708–1714. doi:10.1161/CIRCULATIONAHA.105.602532.
  • Frantz MC, Wipf P. (2010). Mitochondria as a target in treatment. Environ Mol Mutagen, 51, 462–475. doi:10.1002/em.20554.
  • Frijhoff J, Winyard PG, Zarkovic N, et al. (2015). Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal, 23, 1144–1170. doi:10.1089/ars.2015.6317.
  • Gao B, Flores SC, Leff JA, et al. (2003). Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3. Am J Physiol Lung Cell Mol Physiol, 284, L917–25. doi:10.1152/ajplung.00374.2002.
  • Gerschman R, Gilbert DL, Nye SW, et al. (1954). Oxygen poisoning and x-irradiation: a mechanism in common. Science (80- ), 119, 623–626.
  • Gori T, Munzel T. (2011). Oxidative stress and endothelial dysfunction: therapeutic implications. Ann Med, 43, 259–272. doi:10.3109/07853890.2010.543920.
  • Guo C, Sun L, Chen X, Zhang D. (2013). Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neral Regen Res, 8, 2003–2014.
  • Guzik TJ, Chen W, Gongora MC, et al. (2008). Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol, 52, 1803–1809. doi:10.1016/j.jacc.2008.07.063.
  • Hare JM, Stamler JS. (2005). NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest, 115, 509–517. doi:10.1172/JCI24459.
  • Heymes C, Vanderheyden M, Bronzwaer JG, et al. (1999). Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation, 99, 3009–3016.
  • Hingtgen SD, Davisson RL. (2001). Gene therapeutic approaches to oxidative stress-induced cardiac disease: principles, progress, and prospects. Antioxid Redox Signal, 3, 433–449. doi:10.1089/15230860152409077.
  • Ho E, Karimi Galougahi K, Liu CC, et al. (2013). Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol, 1, 483–491. doi:10.1016/j.redox.2013.07.006.
  • Hovatta I, Juhila J, Donner J. (2010). Oxidative stress in anxiety and comorbid disorders. Neurosci Res, 68, 261–275. doi:10.1016/j.neures.2010.08.007.
  • Hrbac J, Kohen R. (2000). Biological redox activity: its importance, methods for its quantification and implication for health and disease. Drug Dev Res, 50, 516–527. doi:10.1002/1098-2299(200007/08)50:3/4<516::AID-DDR35>3.0.CO;2-B.
  • Huang W, Glass CK. (2010). Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arterioscler Thromb Vasc Biol, 30, 1542–1549. doi:10.1161/ATVBAHA.109.191189.
  • Hybertson BM, Gao B, Bose SK, McCord JM. (2011). Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med, 32, 234–246. doi:10.1016/j.mam.2011.10.006.
  • Ikeuchi M, Matsusaka H, Kang D, et al. (2005). Overexpression of mitochondrial transcription factor A ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation, 2005, 683–690. doi:10.1161/CIRCULATIONAHA.104.524835.
  • Jacobson MD. (1996). Reactive oxygen species and programmed cell death. Trends Biochem Sci, 21, 83–86.
  • Jones DP. (2006). Redefining oxidative stress. Antioxid Redox Signal, 8, 1865–1879. doi:10.1089/ars.2006.8.1865.
  • Jones DP, Carlson JL, Mody VC, et al. (2000). Redox state of glutathione in human plasma. Free Radic Biol Med, 28, 625–635.
  • Kaltschmidt B, Sparna T, Kaltschmidt C. (1999). Activation of NF-kappa B by reactive oxygen intermediates in the nervous system. Antioxid Redox Signal, 1, 129–144. doi:10.1089/ars.1999.1.2-129.
  • Keaney Jr. JF, Gaziano JM, Xu A, et al. (1994). Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest, 93, 844–851. doi:10.1172/JCI117039.
  • Kluza J, Marchetti P, Gallego MA, et al. (2004). Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene, 23, 7018–7030. doi:10.1038/sj.onc.1207936.
  • Kohen R, Nyska A. (2002). Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol, 30, 620–650. doi:10.1080/01926230290166724.
  • Leone A, M S Roca, Ciardiello C, Constantini S, Budillon A. 2017. Oxidative stress gene expression profile correlates with cancer patient poor prognosis: identification of crucial pathways might select novel therapeutic approaches. Oxidat Med Cell Longevity doi:10.1155/2017/2597581
  • Libby P. (2002). Inflammation in atherosclerosis. Nature, 420, 868–874. doi:10.1038/nature01323.
  • Libby P. (2006). Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr, 83, 456S–60S. doi:10.1093/ajcn/83.2.456S.
  • Lin B, Xu J, Feng DG, et al. (2018). DUSP14 knockout accelerates cardiac ischemia reperfusion (IR) injury through activating NF-kappaB and MAPKs signaling pathways modulated by ROS generation. Biochem Biophys Res Commun, 501, 24–32. doi:10.1016/j.bbrc.2018.04.101.
  • Liu J, Yang G, Thompson-Lanza JA, et al. (2004). A genetically defined model for human ovarian cancer. Cancer Res, 64, 1655–1663.
  • Liu T, Zhong S, Liao X, et al. (2015). A Meta-analysis of oxidative stress markers in depression. PLoS One, 10, e0138904. doi:10.1371/journal.pone.0138904.
  • Ludke A, Akolkar G, Ayyappan P, et al. (2017). Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C. PLoS One, 12, e0179452. doi:10.1371/journal.pone.0179452.
  • M T L, Beal MF. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443, 787–795. doi:10.1038/nature05292.
  • Marrocco I, Altieri F, Peluso I. (2017). Measurement and clinical significance of biomarkers of oxidative stress in humans. Oxid Med Cell Longev, 2017, doi:10.1155/2017/6501046.
  • Mayyas F, Baydoun D, Ibdah R, Ibrahim K. (2018). Atorvastatin reduces plasma inflammatory and oxidant biomarkers in patients with risk of atherosclerotic cardiovascular disease. J Cardiovasc Pharmacol Ther, 23, 216–225. doi:10.1177/1074248417753677.
  • McCord JM, Fridovich I. (1969). Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem, 244, 6049–6055.
  • Mishra P, Samanta L. 2012. Oxidative stress and heart failure in altered thyroid states. Scientific World J. doi:10.1100/2012/741861
  • Mittal CK, Murad F. (1977). Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3ʹ,5ʹ-monophosphate formation. Proc Natl Acad Sci U S A, 74, 4360–4364.
  • Montuschi P, Barnes P, Roberts 2nd. LJ. (2007). Insights into oxidative stress: the isoprostanes. Curr Med Chem, 14, 703–717.
  • Munzel T, Gori T, Bruno RM, Taddei S. (2010). Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J, 31, 2741–2748. doi:10.1093/eurheartj/ehq396.
  • Pankuweit S, Ruppert V, Maisch B. (2004). Inflammation in dilated cardiomyopathy. Herz, 29, 788–793. doi:10.1007/s00059-004-2626-9.
  • Pashkow FJ. (2011). 2011. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention? Int J Inflam, doi:10.4061/2011/514623.
  • Peng M, Huang L, Xie ZJ, et al. (1995). Oxidant-induced activations of nuclear factor-kappa B and activator protein-1 in cardiac myocytes. Cell Mol Biol Res, 41, 189–197.
  • Pentland AP. (1994). Active oxygen mechanisms of UV inflammation. Adv Exp Med Biol, 366, 87–97.
  • Perluigi M, Coccia R, Butterfield DA. (2012). 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxid Redox Signal, 17, 1590–1609. doi:10.1089/ars.2011.4406.
  • Rajic D, Jeremic I, Stankovic S, et al. (2018). Oxidative stress markers predict early left ventricular systolic dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention. Adv Clin Exp Med, 27, 185–191.
  • Rapola JM, Virtamo J, Ripatti S, et al. (1997). Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet, 349, 1715–1720. doi:10.1016/S0140-6736(97)01234-8.
  • Rashid S, Ali N, Nafees S, et al. (2013). Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods, 23, 337–345. doi:10.3109/15376516.2012.759306.
  • Ray RS, Mehrotra S, Shankar U, et al. (2001). Evaluation of UV-induced superoxide radical generation potential of some common antibiotics. Drug Chem Toxicol, 24, 191–200. doi:10.1081/DCT-100102610.
  • Sawyer DT, Valentine JS. (1981). How super is superoxide? Acc Chem Res, 14, 393–400. doi:10.1021/ar00072a005.
  • Schroder K, Zhang M, Benkhoff S, et al. (2012). Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res, 110, 1217–1225. doi:10.1161/CIRCRESAHA.112.267054.
  • Selemidis S, Sobey CG, Wingler K, et al. (2008). NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther, 120, 254–291. doi:10.1016/j.pharmthera.2008.08.005.
  • Sen CK, Packer L. (1996). Antioxidant and redox regulation of gene transcription. Faseb J, 10, 709–720.
  • Shackelford RE, Kaufmann WK, Paules RS. (2000). Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med, 28, 1387–1404.
  • Shishehbor MH, Brennan ML, Aviles RJ, et al. (2003). Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation, 108, 426–431. doi:10.1161/01.CIR.0000080895.05158.8B.
  • Sies H. (2015). Oxidative stress: a concept in redox biology and medicine. Redox Biol, 4, 180–183. doi:10.1016/j.redox.2015.01.002.
  • Sima P, Vannucci L, Vetvicka V. (2018). Atherosclerosis as autoimmune disease. Ann Transl Med, 6, doi:10.21037/atm.2018.02.02.
  • Smith RA, Murphy MP. (2010). Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci, 1201, 96–103. doi:10.1111/j.1749-6632.2010.05627.x.
  • Soliman AF, Anees LM, Ibrahim DM. (2018). Cardioprotective effect of zingerone against oxidative stress, inflammation, and apoptosis induced by cisplatin or gamma radiation in rats. Naunyn Schmiedebergs Arch Pharmacol, doi:10.1007/s00210-018-1506-4. Epub ahead of print
  • Spickett CM, Pitt AR. (2015). Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology. Antioxid Redox Signal, 22, 1646–1666. doi:10.1089/ars.2014.6098.
  • Stephens JW, Bain SC, Humphries SE. (2008). Gene-environment interaction and oxidative stress in cardiovascular disease. Atherosclerosis, 200, 229–238. doi:10.1016/j.atherosclerosis.2008.04.003.
  • Thankam Finosh G, Jayabalan M. (2013). Reactive oxygen species—control and management using amphiphilic biosynthetic hydrogels for cardiac applications. Adv Biosci Biotechnol, 4, 1134–1146. doi:10.4236/abb.2013.412150.
  • Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. (2013). Markers of oxidative stress during diabetes mellitus. J Biomark, 2013 doi:10.1155/2013/378790.
  • Tousson E, Hafez E, Zaki S, Gad A. (2016). The cardioprotective effects of L-carnitine on rat cardiac injury, apoptosis, and oxidative stress caused by amethopterin. Environ Sci Pollut Res Int, 23, 20600–20608. doi:10.1007/s11356-016-7220-1.
  • Tsukano H, Gotoh T, Endo M, et al. (2010). The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler Thromb Vasc Biol, 30, 1925–1932. doi:10.1161/ATVBAHA.110.206094.
  • Valko M, Leibfritz D, Moncol J, et al. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39, 44–84. doi:10.1016/j.biocel.2006.07.001.
  • Varadharaj S, Kelly OJ, Khayat RN, et al. (2017). Role of dietary antioxidants in the preservation of vascular function and the modulation of health and disease. Front Cardiovasc Med, 4, 64. doi:10.3389/fcvm.2017.00064.
  • Vaya J. (2013). Exogenous markers for the characterization of human diseases associated with oxidative stress. Biochimie, 95, 578–584. doi:10.1016/j.biochi.2012.03.005.
  • Verk B, Nemec Svete A, Salobir J, et al. (2017). Markers of oxidative stress in dogs with heart failure. J Vet Diagn Invest, 29, 636–644. doi:10.1177/1040638717711995.
  • Victorin K. (1994). Review of the genotoxicity of nitrogen oxides. Mutat Res, 317, 43–55.
  • Vivekananthan DP, Penn MS, Sapp SK, et al. (2003). Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet, 361, 2017–2023. doi:10.1016/S0140-6736(03)13637-9.
  • Welsh P, Grassia G, Botha S, et al. (2017). Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? Br J Pharmacol, 174, 3898–3913. doi:10.1111/bph.13818.
  • Zhang R, Brennan ML, Fu X, et al. (2001). Association between myeloperoxidase levels and risk of coronary artery disease. Jama, 286, 2136–2142.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.